Alliance for Alzheimer’s disease and other Dementias
October 4th – 5th 2019, Pavia, Italy
This first congress on Alliance for Alzheimer’s diesease and other Dementias is organised by the University of Pavia, the Institute for Advanced Study and the Mondino… Continue Reading
On September 25th , EBC held its latest event in the European Parliament, this time building on the Value of Treatment‘s work on Alzheimer’s and The Socioeconomic impact of Alzheimer’s in Europe. This event was an opportunity to further present… Continue Reading
Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking.
The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.
The year’s BRAIN prize was awarded to Professors Bart de Strooper (Leuven),Christian Haass (Munich), Michael Goedert (Cambridge) and John Hardy (London) for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease, with far-reaching implications for the… Continue Reading
by Anna Sauerbier
The societal impact of pain (SIP) 2017 Steering Committee Meeting
New techniques target protein clumps linked to Alzheimer’s and cancer
Inside the solitary life of an Alzheimer’s sufferer
E-health Tallinn 2017: i-prognosis… Continue Reading
It is not new that human disease is imposing a burden on the sufferers and a challenge for the physician. While neurologists are having the privilege being physicians and have the single patient in our focus of attention, health economists take a different view. Their thinking is focusing on the burden of disease for the society and its economic implications. They look at the costs of disease in different terms. The classical measures for the burden of disease are the costs in terms of disability-adjusted life years (DALYs) which are defined as the sum of years of life lost due to the disease (YLLs) and years lived with the disease (YLDs) accounting for reduced life time with good quality of life due to the disability. Another important measure is the Socio-demographic Index (SDI) reflecting economic and educational development. There is big science behind all these calculations which I will not go into detail here.
SP on Dementia and Cognitive Disorders Panel met during recent EAN Congress in Amsterdam. Co-chairs Reinhold Schmidt from Austria and Jakub Hort from Czech Republic welcomed members and announced that Prof. Dafin Muresanu from Romania has been appointed as… Continue Reading
by Anna Sauerbier
September is World Alzheimer’s Month
Dementia: why don’t we have any treatments yet?
Standardisation of Alzheimer’s biomarkers’ testing
7th European symposium on the “Societal Impact of Pain” (SIP 2017)
https://www.sip-platform.eu/files/editor/media/sip2017/Proceedings/SIP%202017%20Proceedings_v1.0.pdf… Continue Reading
Report from Dr Célia Carina Machado, from Oliveira Santa Maria, Portugal visiting the Department of Epilepsy, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK, under the supervision of Prof. Ley Sander
Residents and research fellows discover the VUmc
This year’s annual hospital visit on Sunday 25th of June 2017 brought 80 residents and research fellows from all over the world to the impressive VU University Medical Center Amsterdam (VUmc) located in the southwestern part of Amsterdam, close to the campus of VU University. The RRFS hospital visit was organised in collaboration with the Dutch Junior Neurology Association.
by Anna Sauerbier
New Alzheimer Europe publication highlights inequalities in access to dementia care and treatment across Europe
Alzheimer Europe launches European Dementia Monitor 2017 at the European Parliament
Atomic… Continue Reading